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Hierarchical non-negative matrix factorization
applied to three-dimensional 3T MRSI data for
automatic tissue characterization of the
prostate
Teresa Laudadioa*, Anca R. Croitor Savab,c, Diana M. Simab,c,
Alan J. Wrightd, Arend Heerschape, Nicola Mastronardia and
Sabine Van Huffelb,c
In this study non-negative matrix factorization (NMF) was hierarchically applied to simulated and in vivo three-
dimensional 3 T MRSI data of the prostate to extract patterns for tumour and benign tissue and to visualize their
spatial distribution. Our studies show that the hierarchical scheme provides more reliable tissue patterns than those
obtained by performing only one NMF level. We compared the performance of three different NMF implementations
in terms of pattern detection accuracy and efficiency when embedded into the same kind of hierarchical scheme. The
simulation and in vivo results show that the three implementations perform similarly, although one of them is more
robust and better pinpoints the most aggressive tumour voxel(s) in the dataset. Furthermore, they are able to detect
tumour and benign tissue patterns even in spectra with lipid artefacts. Copyright © 2016 John Wiley & Sons, Ltd.
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INTRODUCTION
Automatic and accurate non-invasive tissue characterization is an
unmet need in the diagnosis and treatment-evaluation of
tumours. The most reliable clinical tool to verify the presence of
body tumours is, currently, biopsy, which carries a risk of
morbidity or mortality. Furthermore, each biopsy samples only a
single location in the tumour. Imaging technologies, such as MR
modalities, are desirable as they allow a non-invasive diagnosis
of the whole tumours. MRSI is a potential powerful tool, since it
is able to provide metabolic information that could be used to
localize and characterize tumour tissue non-invasively (1,2).
Currently, prostate MRSI data are often visualized asmetabolite
maps, in which the spatial distributions of the (relative) levels of
metabolites in prostate cancer are displayed (3–5). Indeed,
differences between normal prostate gland tissue, containing
high levels of citrate (Citr), and prostate tumour tissue, which
has higher levels of choline (Cho) containing compounds, have
been observed (4). Quantification of these metabolite signals,
however, may still be cumbersome if spectra have low signal to
noise ratio (SNR) or broad overlapping peaks, or contain artefacts.
Furthermore, quantification may be suboptimal due to
differences among the spectra of different voxels (e.g. frequency
shifts, line widths). Spectral pre-processing and visual quality
control (QC) are often user dependent and time consuming,
especially in the case of three-dimensional MRSI.
Alternatively, automatic segmentation and classification
methods have been proposed for prostate MRSI data. These
consist of supervised pattern recognition approaches that
exploit prior knowledge in the form of models or a training set
(6,7) in order to detect tumour voxels. However, such methods
may be limited to MRSI data with particular acquisition
parameters. Recently, a blind source separation (BSS) method
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known as non-negative matrix factorization (NMF) (8) has been
applied to MRSI data of the brain (9–12) to extract tissue specific
metabolic patterns without the need for any prior tissue model
and without imposing strong statistical constraints. This is an
advantage compared with other methods, such as independent
component analysis (ICA) and principal component analysis,
which assume mutual independence and uncorrelation among
sources, respectively. Indeed, these constraints may not apply
to in vivo MRSI data since spectra from different tissues can be
correlated (10). Furthermore, NMF provides not only tissue
specific metabolic patterns, but also their corresponding
abundances, i.e. the contribution of extracted patterns to the
spectra in each MRSI voxel. These allow a proper assessment of
tissue mixtures, thereby representing an improvement over
classical classification algorithms that label each voxel either as
tumour or benign.
In the assessment of brain MRSI data by NMF, a hierarchical
approach has been used consisting of progressively applying
several NMF levels (9,10,12). Here, we propose an alternative
recursive–hierarchical application of NMF (HNMF) to assess
three-dimensional MRSI data of the prostate obtained at 3 T.
We investigated and compared the performance of HNMF in
accuracy of pattern detection with that of the non-hierarchical
approach, which consists of only one NMF level. Moreover, since
several NMF algorithms are available in the literature, we
considered three different implementations: ALS-NMF (13),
aHALS-NMF (14) and CONVEX-NMF (15). ALS-NMF is the most
popular implementation in the BSS community; CONVEX-NMF
and aHALS-NMF were successfully applied to brain MRSI data
and were proven to perform better than other implementations
(11,12). We embedded such implementations into HNMF, which
formed the basis of an automatic tissue characterization method.
Depending on the considered NMF algorithm, we denoted the
method by ALS-HNMF, aHALS-HNMF and CONVEX-HNMF,
respectively.
The three variants of the method were applied to simulated as
well as to in vivo prostate MRSI data, and their performances
were compared in terms of accuracy and efficiency.
EXPERIMENT
Simulation set-up
Two different simulated MRSI datasets were considered in order to
assess the performance of the proposed tissue characterization
approach: a dataset characterized only by tumour and benign
tissue (Dataset 1), and a dataset including lipid artefacts (Dataset 2).
The simulated datasets were obtained as follows. Two MR
spectral profiles, representing pure tumour and benign tissue
(top left plots in Fig. 1), were considered as theoretical models
and linearly combined in different percentages to simulate 10
MRSI datasets. The two spectral profiles were created based on
the prior knowledge that proton MR spectra of the prostate
contain only signals from Cho, spermine (Spm), creatine (Cr)
and Citr, with tumour regions characterized by spectra with
higher Cho and reduced Citr signals (3–5) (Appendix).
Each dataset consists of a grid of spectra computed as follows:
s ¼ at þ 1 að Þb; [1]
where t and b stand for the pure tumour and benign model
spectra, respectively, and a ∈ [0, 1] gives the proportion of
tumour in each voxel.
Furthermore, spectra were randomly frequency shifted by up
to ±0.0396 ppm to simulate realistic MRSI datasets. The
aforementioned values cover the typical shifts occurring in
in vivo datasets such as those described in the next subsection.
Dataset 1 consists of a 10 × 10 grid of voxels mimicking a
highly aggressive prostate tumour (bottom middle image in
Fig. 1), where the contribution of the pure tumour model ranges
from 20% to 80%. The spectrum with the highest contribution of
the pure tumour model is displayed in Fig. 1, bottom left image.
Dataset 2 was obtained by adding a region containing lipid
artefacts to Dataset 1 (blue region in the bottom right image of
Fig. 1). The lipid signal (Lip – top right image in Fig. 1) was
modelled as a broad Lorentzian peak (16) with line width
comparable to that of the lipid signals observable in the
available in vivo datasets.
Signals were perturbed by adding different levels of Gaussian
noise with known standard deviation (SD). Each spectrum was
normalized by dividing it by its l2-norm (17).
In vivo MRSI examinations
Three-dimensional 3 T MRSI data were acquired in six patients
affected by prostate cancer with different Gleason scores (GSs) at
the Radboud University Medical Centre (RUMC, Nijmegen, The
Netherlands) on a Siemens (Erlangen, Germany) Magnetom Trio
scanner as follows: an endorectal surface coil (MEDRAD, Bayer
HealthCare, Whippany, NJ, USA) was combined with body array
coils for signal reception; a Mescher–Garwood point resolved
spectroscopy (MEGA-PRESS) pulse sequence was used with TE
=145ms, TR =750ms, number of phase-encoding steps (x, y, z)
= 12 and a vector size of 512 points at a receiver bandwidth of
1250Hz (18,19). MEGA pulses (20) were applied for frequency-
selective water and fat suppression, and spatial lipid saturation slabs
were placed around the volume of interest (VOI). The MRSI field of
view, matrix size and number of weighted acquisitions were
adapted to the individual patient, resulting in a nominal voxel size
Figure 1. Top row (from left to right): prostate model magnitude
spectra assumed for pure tumour, benign tissue and lipids. Bottom
row: most aggressive tumour spectrum in Datasets 1 and 2; nosologic
image for Dataset 1; nosologic image for Dataset 2. Voxel colours range
from red (aggressive tumour) to green (benign tissue) to blue (lipids).
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before apodization of either 5×5×5mm3 or 6×6×6mm3 in a
total acquisition time of 9min. The study was approved by the
ethical committee. All patients subsequently underwent radical
prostatectomy, and a prostate specimen was fixated with formalin
and labelled by inking of the surface, followed by serially sectioning
at 4mm intervals perpendicular to the dorsal–rectal surface (21).
The resulting slices were macroscopically photographed. A urologic
pathologist outlined the location of the tumour on these
histopathological images and graded each focus according to
Reference (22). Patients were then staged following the 2002 TNM
classification (23).
In this paper we used the histological photographs to illustrate
the localization of the tumour foci, but a registration correcting for
distortions was not performed. The MRSI voxels within the tumour
or normal region, as outlined based on the histopathological
images, were labelled by an expert spectroscopist as ‘tumour’ or
‘normal’, provided that these spectra were of sufficient quality
(sufficient SNR, absence of lipid signals and absence of baseline
distortions). The experts’ criteria for defining acceptable SNR and
unacceptable lipid and baseline distortions are reported in
Reference (24). For each patient, the selected signals were fitted
using a prototype software package (Metabolite Report, Siemens).
Since Cho/Citr or (Cho+Cr)/Citr are often used as biomarkers to
detect tumour tissue in prostate, among the tumour labelled voxels
the voxel characterized by the spectrumwith highest (Cho+Cr)/Citr
was determined and assigned as the most aggressive tumour voxel
(21). This spectrum was used in the in vivo studies to evaluate the
accuracy of the tumour pattern provided by the method proposed
in this paper.
THEORY AND METHOD
NMF
NMF is a BSS technique imposing non-negative constraints on
the extracted sources and corresponding weights. Specifically,
given a non-negative matrix XͼRmxn, and an integer k
(0< k<min(m, n)) representing the number of sources to extract,
two non-negative matrices, WͼRmxk (source matrix) and HͼRkxn
(weight matrix), are estimated by minimizing the functional
f W;Hð Þ ¼ 1
2
X WHk k2F [2]
where the subscript F stands for the Frobenius norm (17). It is
worth noticing that, given the non-convex nature of f(W,H), its
minimization may lead to the estimation of local minima and
does not admit a unique solution. Several NMF algorithms have
been proposed in order to deal with this problem (13). In this
paper we consider the following ones:
1 ALS-NMF (13), available in MATLAB (MathWorks, Natick,
Massachusetts, USA) and based on an alternating least
squares scheme;
2 aHALS-NMF (14), an accelerated version of the hierarchical
alternating least-squares scheme proposed in Reference (25);.
3 CONVEX-NMF (15), where the columns of W, i.e. the sources,
are restricted to convex combinations of the columns of the
data matrix X.
Starting values for aHALS-NMF and CONVEX-NMF, whenever
applied, will be provided by ALS-NMF.
In the following, the above NMF implementations will be
embedded into the recursive hierarchical scheme we propose
in this paper, i.e. HNMF, and this will be included in an automatic
tissue characterization method, which, depending on the
considered NMF variant, will be respectively denoted by ALS-
HNMF, aHALS-HNMF and CONVEX-HNMF.
Tissue characterization method based on HNMF
The input to NMF consists of a matrix where the pre-processed
MRSI magnitude spectra are stacked as columns. NMF was first
applied to each dataset by setting k, the number of tissues to
detect, equal to 2. Nevertheless, preliminary results revealed this
approach to be unreliable, and we therefore embedded NMF
into the recursive–hierarchical scheme described later (see Tissue
characterization method). The hierarchical scheme generates
many tissue-representative spectral profiles from increasingly
finer partitions of the MRSI grid.
The in vivo MR spectra were pre-processed by HLSVD-PRO (26)
in order to remove water and lipid contributions. Furthermore,
an automatic and fast QC algorithm (24) was applied to assess
the quality of each spectrum in the VOI. Only spectra labelled
as of sufficient quality, here denoted as QC spectra, were
considered for further analysis.
Tissue characterization method
Step 1. HNMF.
The MRSI dataset is arranged into a matrix X, containing spectra
as columns, and NMF is applied to X by setting k= 2. Two source
signals and their corresponding weights are obtained.
The columns in the source matrix W are normalized by dividing
each column by its l2-norm, and the rows in the weight matrix
H are scaled accordingly. The given MRSI voxels are divided into
two new datasets by assigning each voxel to the source signal
characterized by the maximum weight in that voxel.
The procedure is recursively repeated after building new Xmatrices
from spectra pertaining to each of the subsets obtained above.
In this study, four NMF levels, corresponding to increasingly
finer partitions of the initial MRSI data, were applied and a
cumulative number of 30 source signals were obtained. Two
sources, representing tumour and benign tissues, were
automatically selected as tissue patterns based on the prior
knowledge that Cho/Citr should be high for tumour and low
for benign tissue. Moreover, the source with the most
predominant peak in the region (1.7 ppm–2.3 ppm) was selected
as the lipid pattern. The selection procedure used integration to
determine peak amplitudes.
Step 2. Non-negative least squares (NNLS) (27) is applied to X by
simultaneously using the final patterns of Step 1 as regressors.
Coefficient vectors are obtained (one for each pattern), which
can be plotted for their MRSI voxel’s positions to give tissue
maps. These maps are encoded as colour channels in an RGB
image, thereby providing a simultaneous visualization of the
considered tissues as well as of their mixture. Such an image is
called an unsupervised nosologic image (9), as different tissue
types are denoted by different colours: red for tumour, green
for benign tissue, blue for lipids, and their possible mixture for
mixed tissue.
A pseudocode along with some MATLAB codes is available at
http://users.ba.cnr.it/iac/irmanm21/Welcome_Teresa_files/
HNMF_codes.pdf.
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Performance measures
The performance of ALS-HNMF, aHALS-HNMF and CONVEX-
HNMF is assessed in terms of detection accuracy and efficiency.
Specifically, the pattern detection accuracy is estimated by
computing the correlation coefficient (CorCoef) between the
final tissue patterns provided by each variant of the method
and the assumed spectral tissue models. The spatial detection
accuracy is obtained by computing the CorCoef between the
coefficients in the tissue maps provided by NNLS and those in
the simulated maps.
Finally, in the in vivo studies, Cho/Citr maps are estimated by
peak integration and are compared with the tumour maps
provided by the NMF-based methods.
RESULTS
Simulation studies
One ALS-NMF level with k= 2, and Step 1 of ALS-HNMF, aHALS-
HNMF and CONVEX-HNMF, were applied to Dataset 1 with a
medium noise level (SD= 0.04). The detected tumour (red) and
benign (green) tissue patterns are superimposed on the
theoretical models (black) in Fig. 2.
The CorCoef values between the detected patterns and the
theoretical models as well as the spatial CorCoef values were
estimated (Table 1). Such values show that the hierarchical
approach significantly outperforms the single-level ALS-NMF.
The results obtained in Step 2 of ALS-HNMF are displayed in
Fig. 3. The pathological region is visualized in red in the
nosologic image and it corresponds well to the original
simulated one (bottom middle image of Fig. 1).
ALS-HNMF, aHALS-HNMF and CONVEX-HNMF were applied to
Dataset 1 and Dataset 2 over 300 simulation runs for different
noise levels. The CorCoef means and corresponding SDs (see
Figs. 4 and 5) reveal excellent performance of the three HNMF
implementations for Dataset 1. Good values are obtained for
Dataset 2 except for the largest noise level, SD= 0.1.
Furthermore, although the three methods perform similarly,
CONVEX-HNMF is more robust as it generally exhibits the lowest
SDs.
All the implementations are efficient as they require about 1 s
of computation time to process each dataset.
In vivo studies
Tests were also carried out on the in vivo datasets described
earlier to validate the results obtained by the simulation studies.
The CorCoef values between the final patterns and the
corresponding theoretical models, between the tumour pattern
and the most aggressive tumour spectrum selected by the
experts and between the tumour map and the Cho/Citr map
for all the considered patients are reported in Table 2 (Columns
5–8). Observe that CONVEX-HNMF always provides the detection
results that best correlate with the most aggressive tumour
spectrum and with the Cho/Citr map (Columns 7 and 8,
respectively). For Patients 3 and 6, ALS-HNMF performs best in
terms of tumour pattern detection compared with the ‘pure’
tumour model. It is worth observing that for Patient 2 the
extracted tumour patterns are weakly correlated with the most
aggressive tumour spectrum. A visual inspection of this
spectrum revealed that it contains a significant Citr peak, while
the three implementations of HNMF detect patterns without or
very low Citr contribution. The reason for this difference is that
expert labelling only involved some of the QC spectra, and in this
case did not consider spectra with a low contribution of Citr.
Also in the case of Patient 6, ALS-HNMF and aHALS-HNMF
provide a tumour pattern that is weakly correlated with the most
aggressive tumour spectrum. CONVEX-HNMF finds a tumour
pattern better correlated with the aforementioned spectrum,
Figure 2. From top to bottom: sources obtained by applying to Dataset
1 one level of ALS-NMF with k = 2 (first row plots), final tumour (red) and
benign (green) tissue patterns provided by ALS-HNMF (second row),
aHALS-HNMF (third row) and CONVEX-HNMF (fourth row), superimposed
on the theoretical tissue models (black).
Table 1. Simulation results obtained by applying one ALS-
NMF level with k= 2, ALS-HNMF, aHALS-HNMF and
CONVEX-HNMF to dataset 1 for one simulation run and
SD=0.04. CorCoef between detected tumour patterns and
tumour model (a), benign patterns and benign model (b),
NNLS tumour maps and simulated tumour map (c) and NNLS
benign maps and simulated benign tissue map (d)
Methods (a) (b) (c) (d)
ALS-NMF (k= 2) 0.5054 0.8889 0.3005 0.6940
ALS-HNMF 0.9074 0.9734 0.9581 0.9829
aHALS-HNMF 0.9486 0.9584 0.9623 0.9852
CONVEX-HNMF 0.8736 0.9739 0.9615 0.9775
Figure 3. Tissue maps and nosologic image obtained by ALS-HNMF for
Dataset 1 in one simulation run with SD = 0.04. In the nosologic image
the pathological and benign regions are visualized with the red and
green intensities, respectively.
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although this pattern is the least correlated with the theoretical
tumour model.
The detection results obtained by CONVEX-HNMF for Patient 1
are displayed in Fig. 6 as an example of HNMF analysis. The QC
algorithm was applied to the spectra inside the VOI, revealing
that spectra of sufficient quality are mostly located in Slices 5–
10. The percentage of voxels discarded by the QC algorithm
was 13% for the illustrated slice, 17% over slices 5–10, and 38%
over all slices. CONVEX-HNMF was applied to the QC spectra
and provided tumour (red curve in Fig. 6) and benign (green
curve) tissue patterns highly correlated with the theoretical
Figure 5. Dataset 2. Means (plots in Columns 1 and 3) and corresponding SDs (plots in Columns 2 and 4) of the CorCoef values between the final tissue
patterns and the corresponding theoretical models (Columns 1 and 2), and of the spatial CorCoef values (Columns 3 and 4) obtained with ALS-HNMF
(blue), aHALS-HNMF (red) and CONVEX-HNMF (green) over 300 runs and for different SDs.
Table 2. In vivo results. Column 5, CorCoef between the
tumour pattern (TP) and the theoretical tumour model (TM);
column 6, CorCoef between the benign tissue pattern (BP)
and the theoretical benign model (BM); column 7, CorCoef
between the tumour pattern and the most aggressive
tumour spectrum (MAT) provided by expert labelling; column
8, mean CorCoef value over all slices between the tumour
map (Tmap) and the Cho/citr map
Patients Age GS Methods
(HNMF)
TP
versus
TM
BP
versus
BM
TP
versus
MAT
Tmap
versus
Cho/Citr
1 61 4 + 3 ALS 0.8668 0.9458 0.8259 0.9673
aHALS 0.8748 0.8162 0.8400 0.9748
CONVEX 0.8728 0.9425 0.8510 0.9764
2 66 4+ 3 ALS 0.9128 0.9327 0.5900 0.9404
aHALS 0.9060 0.9557 0.4888 0.9264
CONVEX 0.9014 0.9300 0.6624 0.9659
3 67 4+ 3
+ 5
ALS 0.8722 0.9193 0.7929 0.9429
aHALS 0.8193 0.9233 0.6702 0.9033
CONVEX 0.7568 0.9299 0.8540 0.9629
4 64 3 + 4,
4 + 3
ALS 0.8851 0.9246 0.7811 0.9108
aHALS 0.8541 0.9026 0.7060 0.8891
CONVEX 0.8897 0.9290 0.8686 0.9655
5 70 4 + 3,
3 + 3
ALS 0.8438 0.9584 0.5863 0.8687
aHALS 0.8164 0.9587 0.5648 0.8404
CONVEX 0.8095 0.9647 0.7865 0.9225
6 66 4+ 3
+ 5
ALS 0.7287 0.9599 0.5762 0.8540
aHALS 0.6104 0.9654 0.3448 0.8085
CONVEX 0.4351 0.9578 0.9096 0.9349
Figure 4. Dataset 1. Means (plots in Columns 1 and 3) and
corresponding SDs (plots in Columns 2 and 4) of the CorCoef values
between the final tissue patterns and the corresponding theoretical
models (Columns 1 and 2), and of the spatial CorCoef values (Columns
3 and 4) obtained with ALS-HNMF (blue), aHALS-HNMF (red) and
CONVEX-HNMF (green) over 300 runs and for different SDs.
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models (black curves) as well as with the most aggressive
tumour spectrum (blue curve in the top left plot). Moreover, in
agreement with histopathology, the nosologic image correctly
visualizes the pathological region, and the tumour map
corresponds very well to the Cho/Citr map, as also confirmed
by the CorCoef value in Table 2 (Column 8).
DISCUSSION
In this paper NMF was hierarchically applied to simulated as well
as to in vivo prostate MRSI data in order to extract characteristic
patterns for prostate tissues and to visualize their spatial
distributions by means of unsupervised nosologic images. These
colour images summarize the spectral information from the MRSI
dataset measured in a patient. Although they do not represent
tumour probability maps and they cannot be compared across
patients, these images are an efficient way to visualize the spatial
distribution of relevant tissue patterns in the dataset. They
should only be interpreted together with the corresponding
extracted tissue patterns.
NMF algorithms have already been applied successfully to
brain MRSI data, but, to our knowledge, this study represents
the first example of application of NMF to prostate MRSI data.
In the simulation studies, the MRSI spectra were generated
using only two models for ‘pure’ tumour spectra and benign
spectra (1). This is a simplified approach to real prostate MRSI
data, which may also present different spectral features, both
in the benign tissue (e.g. differences between peripheral and
central gland, partial volume from the seminal vesicle areas)
and in the tumour (e.g. differences between tumour grades).
We first observed that, for all the considered NMF
implementations, the hierarchical scheme provides tissue
patterns of higher quality than those from one NMF level with
k equal to the number of tissue patterns to detect. Applying
one NMF level by increasing the value of k would also be
possible, but an automatic selection of the optimal k ensuring
the presence of both the tumour and benign tissue patterns
among the obtained sources is needed. This represents a model
order selection problem and is beyond the scope of the present
paper.
The second objective of our study was to compare the
performance of ALS-HNMF, aHALS-HNMF and CONVEX-HNMF
in detection accuracy and efficiency.
The simulation results showed that the three considered
variants of the method perform similarly. Nevertheless,
CONVEX-HNMF is recommended since it is more robust and
always provides patterns that are linear combinations of the
existing spectra in the MRSI dataset. Indeed, it better pinpoints
the most aggressive tumour voxel(s) because the tumour pattern
is very similar to some of the spectra in the dataset. Regarding
aHALS-HNMF, the simulation studies showed its tendency to find
sources that are less correlated with each other, e.g. a source that
was flat or had a dip where the second source had a peak. Thus,
aHALS-HNMF would be more appropriate if the aim is to find the
underlying uncorrelated sources in the data, but less appropriate
if the goal is to detect and visualize the most aggressive part of
the MRSI dataset. Finally, ALS-HNMF sometimes shows a
behaviour similar to that of CONVEX-HNMF, sometimes to that
of aHALS-HNMF, without a clear trend.
Regarding the tumour region detection, the spatial CorCoef
values revealed that the three variants perform similarly. This is
not perfectly in agreement with the results obtained for the
tumour pattern detection, where CONVEX-HNMF showed a
slightly worse performance. This is due to the shape of the most
aggressive tumour spectra, which often contain a Citr
contribution, while no Citr multiplet is present in our ‘pure’
tumour model.
Several advantages characterize the method proposed in this
paper when compared with either the classical approach based
on the estimation of metabolite maps or other NMF-based
algorithms. Indeed, as shown in the in vivo studies, our method
automatically provides tumour maps that are highly correlated
with the Cho/Citr maps, but they also correlate to the underlying
Figure 6. Patient 1. Top plots: tumour (red) and benign (green) tissue patterns obtained by CONVEX-HNMF versus theoretical models (black) and
versus the most aggressive tumour spectrum (blue spectrum in the left-hand plot). Bottom images, from left to right: histopathological image where
the tumour region is indicated on a resected slice of the prostate approximately corresponding to the axial image; tissue maps obtained by Step 2;
nosologic image; Cho/Citr map. In the maps only the good quality voxels are visualized. In the nosologic image the pathological area is displayed in
red, the benign tissue in green and mixed tissue in a mixture of the aforementioned colours. In the Cho/Citr map, the higher the intensity of colour
the larger the Cho/Citr value in the considered voxel.
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tissue pattern. It thus gives a direct and simultaneous
visualization of the tissue pattern distributions without the need
for any thresholding procedure, and it also accommodates the
visualization of tissue mixtures.
Moreover, the construction of metabolite maps may be
difficult if signals contain broad overlapping peaks or have
artefacts or differences in frequency shifts and line widths. In this
paper, the first two limitations were overcome by applying two
automatic pre-processing algorithms, i.e. HLSVD-PRO and the
QC algorithm. The former was used to filter out the water and
lipid contributions; the latter was applied to select spectra of
sufficient quality.
The results of the QC algorithm showed that acceptable
spectra are mostly located in the middle slices. Furthermore,
the simulation studies revealed that possible lipid artefacts can
be detected as separate sources without significantly affecting
the accuracy of the tumour and benign tissue patterns. Here, it
is worth highlighting that slightly worse results were obtained
for the tumour pattern when processing Dataset 2. These are
due to the pattern selection criterion adopted in Step 1 of the
method. Indeed, sometimes the source signal exhibiting the
highest Cho/Citr contains also a lipid peak, thereby affecting
the performance of the method in terms of CorCoef values. Such
a drawback can be overcome by properly modifying the above
criterion to take into account not only Cho and Citr, but also
lipids.
Obviously, when the water signal is not filtered out, the
predominant water peak will strongly affect the HNMF source
extraction. Therefore, water removal is recommended before
applying HNMF.
Concerning possible differences among spectra, frequency
shifts were included in the simulation studies. In general, the
approximate linear model assumed by HNMF is not satisfied
when spectra within an MRSI dataset have significantly different
frequency shifts or line widths, which might arise from an
inhomogeneous magnetic field. Nevertheless, a priori correction
is non-trivial and has not been applied, since Step 1 of the
method provides a cumulative number of 30 source signals:
some of them are possible candidates for tumour tissue, some
for benign tissue and the remaining ones for mixed tissue, but
all of them capture the most representative frequency shifts
and line widths occurring in the whole dataset. The NNLS step
(Step 2 of the method) would lead to nosologic images where
the spectra affected by too large distortions (e.g. broad line
widths) are not well modelled by the final sources. Such
modelling errors could be visualized as an error map as
proposed in Reference (9).
Regarding the comparison with other NMF-based algorithms,
in the first section we refer to several NMF algorithms developed
for processing brain MRSI data, i.e. References (9–12). In
particular, the main purpose of the methods proposed in
References 10 and 11 consists in the separation of tumour versus
non-tumour tissue, which does not take into account the fact
that the detection of other characteristic pure tissues is crucial
for therapy planning. In contrast, as reported above, HNMF can
be applied to detect more than two pure tissue types (i.e.
tumour, benign and lipid tissue) along with their mixtures. An
alternative method is described in References (9) and (12), which
could be properly modified and applied to prostate MRSI data.
Nevertheless, it assumes that the first NMF level in the
hierarchical scheme is able to extract an accurate healthy tissue
pattern and the second NMF level is only aimed at differentiating
abnormal tissue patterns. In the case of prostate MRSI data, our
studies show that the first NMF level does not provide a reliable
benign tissue pattern. Furthermore, in References (9) and (12) a
thresholding procedure is included in the second NMF level,
which makes the algorithm slightly more complex and
computationally more expensive than our method.
Finally, HNMF would be expected to work similarly for data
acquired with different MRSI sequences. These sequences would
have different underlying spectral tissue patterns depending on
the repetition and echo times.
Despite the attractive properties listed above, an open
problem is represented by the choice of the NMF levels to
include in Step 1 of the method. Our studies show that four
NMF levels allow the extraction of high quality tissue patterns.
Nevertheless, an automatic procedure would be desirable rather
than the heuristic one adopted in this study, and this will be the
subject of future research.
CONCLUSIONS
We propose an automatic and fast tissue characterization
method, based on a hierarchical application of NMF to prostate
MRSI data. The method is able to detect tissue-representative
patterns and to visualize their spatial distributions without
requiring prior tissue models or strong statistical constraints.
Moreover, some data pre-processing steps may not be needed
because the method appears to provide good results even in
the presence of low SNR signals, lipid artefacts and variations
in chemical shift among voxels.
Since several NMF algorithms are available in the literature, we
compared the performance of three different NMF
implementations in terms of pattern detection accuracy and
efficiency when embedded in the proposed method. Our studies
show that CONVEX-HNMF is the most robust variant and it better
pinpoints the most aggressive tumour voxel(s) in the dataset.
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APPENDIX
Generation of Prostate mrs Profiles
The benign and pure tumour spectral profiles were obtained by
quantification of three-dimensional 3T MRSI metabolite signals
measured in patients affected by prostate cancer. Voxels within
tumour or benign tissue were selected as part of a previous
study (21) with a further selection for those that passed the QC
algorithm. Basis spectra for Cho, Cr, Spm and Citr were
generated with NMRSIM (Bruker, Karlsruhe, Germany) using a
simulated MRSI sequence (28) with the same timings as the
acquisition sequence (18). These basis spectra were then used
to quantify the set of spectra using LCModel (29). The relative
concentrations of the different metabolites for all the benign
spectra were used to calculate the relative mean metabolite
concentrations present in benign tissue. The benign tissue
model spectrum is a combination of the four model metabolite
spectra at these relative mean amounts. Concerning the pure
tumour model, it was assumed that the spectra would consist
of only Cho and Cr signals (3). ICA was performed on the full
set of spectra to provide two components, one of which
consisted of only two clear peak-like features corresponding to
the chemical shifts of Cho and Cr. The relative amplitudes of
these two ‘peaks’ were used to simulate the pure tumour model
from a sum of the Cho and Cr simulated spectra.
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